NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") (NASDAQ:AMLX) securities between November 11, 2022 and November 8, 2023, inclusive (the "Class Period").
The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) AMX0035's ...
AMLX)>Full story available on Benzinga.com